312 related articles for article (PubMed ID: 33906653)
1. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
3. Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.
Klont F; Horvatovich P; Bowler RP; van Rikxoort E; Charbonnier JP; Kwiatkowski M; Lynch DA; Humphries S; Bischoff R; Ten Hacken NHT; Pouwels SD
Respir Res; 2022 Jan; 23(1):15. PubMed ID: 35073932
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
[TBL] [Abstract][Full Text] [Related]
5. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
6. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
8. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
12. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.
Kitaguchi Y; Fujimoto K; Hanaoka M; Honda T; Hotta J; Hirayama J
Int J Chron Obstruct Pulmon Dis; 2014; 9():805-11. PubMed ID: 25114520
[TBL] [Abstract][Full Text] [Related]
14. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes.
Cho MH; Castaldi PJ; Hersh CP; Hobbs BD; Barr RG; Tal-Singer R; Bakke P; Gulsvik A; San José Estépar R; Van Beek EJ; Coxson HO; Lynch DA; Washko GR; Laird NM; Crapo JD; Beaty TH; Silverman EK;
Am J Respir Crit Care Med; 2015 Sep; 192(5):559-69. PubMed ID: 26030696
[TBL] [Abstract][Full Text] [Related]
15. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.
Carolan BJ; Hughes G; Morrow J; Hersh CP; O'Neal WK; Rennard S; Pillai SG; Belloni P; Cockayne DA; Comellas AP; Han M; Zemans RL; Kechris K; Bowler RP
Respir Res; 2014 Oct; 15(1):127. PubMed ID: 25306249
[TBL] [Abstract][Full Text] [Related]
16. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.
Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A
Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842
[No Abstract] [Full Text] [Related]
17. FEV
Bhatt SP; Nakhmani A; Fortis S; Strand MJ; Silverman EK; Sciurba FC; Bodduluri S
Am J Respir Crit Care Med; 2023 Sep; 208(6):676-684. PubMed ID: 37339502
[No Abstract] [Full Text] [Related]
18. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.
Tejwani V; Fawzy A; Putcha N; Castaldi PJ; Cho MH; Pratte KA; Bhatt SP; Lynch DA; Humphries SM; Kinney GL; D'Alessio FR; Hansel NN;
Chest; 2021 Oct; 160(4):1245-1254. PubMed ID: 34029566
[TBL] [Abstract][Full Text] [Related]
19. Airway tree caliber heterogeneity and airflow obstruction among older adults.
Vameghestahbanati M; Kingdom L; Hoffman EA; Kirby M; Allen NB; Angelini E; Bertoni A; Hamid Q; Hogg JC; Jacobs DR; Laine A; Maltais F; Michos ED; Sack C; Sin D; Watson KE; Wysoczanksi A; Couper D; Cooper C; Han M; Woodruff P; Tan WC; Bourbeau J; Barr RG; Smith BM;
J Appl Physiol (1985); 2024 May; 136(5):1144-1156. PubMed ID: 38420676
[TBL] [Abstract][Full Text] [Related]
20. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
